Asset Details
Do you wish to reserve the book?
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Do you wish to request the book?
HIV infection: epidemiology, pathogenesis, treatment, and prevention
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
HIV infection: epidemiology, pathogenesis, treatment, and prevention
2014
Overview
HIV prevalence is increasing worldwide because people on antiretroviral therapy are living longer, although new infections decreased from 3·3 million in 2002, to 2·3 million in 2012. Global AIDS-related deaths peaked at 2·3 million in 2005, and decreased to 1·6 million by 2012. An estimated 9·7 million people in low-income and middle-income countries had started antiretroviral therapy by 2012. New insights into the mechanisms of latent infection and the importance of reservoirs of infection might eventually lead to a cure. The role of immune activation in the pathogenesis of non-AIDS clinical events (major causes of morbidity and mortality in people on antiretroviral therapy) is receiving increased recognition. Breakthroughs in the prevention of HIV important to public health include male medical circumcision, antiretrovirals to prevent mother-to-child transmission, antiretroviral therapy in people with HIV to prevent transmission, and antiretrovirals for pre-exposure prophylaxis. Research into other prevention interventions, notably vaccines and vaginal microbicides, is in progress.
Publisher
Elsevier Ltd,Elsevier,Elsevier Limited
Subject
Acquired immune deficiency syndrome
/ AIDS
/ Anti-HIV Agents - therapeutic use
/ Biological and medical sciences
/ Child
/ Drug use
/ Female
/ HIV
/ HIV Infections - epidemiology
/ HIV Infections - transmission
/ Human immunodeficiency virus
/ Humans
/ Infectious Disease Transmission, Vertical - prevention & control
/ Infectious Disease Transmission, Vertical - statistics & numerical data
/ Male
/ Pregnancy Complications, Infectious - epidemiology
/ Pregnancy Complications, Infectious - therapy
We currently cannot retrieve any items related to this title. Kindly check back at a later time.